
Achieve Life Sciences ACHV
€ 2.77
-0.93%
Geschäftsbericht 2025
hinzugefügt 24.03.2026
Achieve Life Sciences P/B 2011-2026 | ACHV
P/B Jährlich Achieve Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.88 | 4.45 | -62.3 | 5.8 | 2.25 | 0.591 | 0.251 | 0.324 | 0.968 | 0.853 | 0.461 | 1.07 | 4.32 | 2.72 | 4.37 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.88 | -62.3 | -1.87 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.36 | -2.52 % | $ 362 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
DBV Technologies S.A.
DBVT
|
16.7 | $ 20.25 | -0.54 % | $ 2.83 B | ||
|
Dyadic International
DYAI
|
25.5 | $ 0.87 | 0.59 % | $ 31.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.78 | 4.83 % | $ 9.09 B | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.6 | -2.26 % | $ 16.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Fate Therapeutics
FATE
|
0.585 | $ 1.14 | -4.2 % | $ 135 M | ||
|
Forte Biosciences
FBRX
|
5.5 | $ 26.44 | - | $ 342 M | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Fennec Pharmaceuticals
FENC
|
4.76 | $ 6.16 | -4.05 % | $ 176 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
Amicus Therapeutics
FOLD
|
16.1 | $ 14.46 | 0.03 % | $ 4.46 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Fulcrum Therapeutics
FULC
|
0.00154 | $ 7.57 | -3.32 % | $ 480 K | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Galectin Therapeutics
GALT
|
-1.41 | $ 2.28 | -11.13 % | $ 146 M | ||
|
Gilead Sciences
GILD
|
3.11 | $ 138.34 | -1.28 % | $ 172 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
0.0645 | $ 0.54 | 4.28 % | $ 503 K | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Genmab A/S
GMAB
|
8.26 | $ 27.14 | -2.2 % | $ 17 B | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 88.2 | -3.37 % | $ 27.2 B | ||
|
Gossamer Bio
GOSS
|
-0.875 | $ 0.32 | -7.11 % | $ 73.1 M | ||
|
Coherus BioSciences
CHRS
|
3.71 | $ 1.62 | -3.29 % | $ 190 M | ||
|
Grifols, S.A.
GRFS
|
1.15 | $ 7.98 | -3.04 % | $ 6.83 B | ||
|
Akari Therapeutics, Plc
AKTX
|
285 | $ 3.5 | -1.13 % | $ 236 B | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
GT Biopharma
GTBP
|
0.382 | $ 0.41 | -8.56 % | $ 2.26 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
51.7 | $ 316.69 | -4.13 % | $ 41.5 B | ||
|
Halozyme Therapeutics
HALO
|
198 | $ 63.72 | 1.01 % | $ 7.64 B | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
0.702 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Harmony Biosciences Holdings
HRMY
|
1.85 | $ 27.53 | -0.67 % | $ 1.58 B | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 4.53 | 1.0 % | $ 726 M | ||
|
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M |